22270-22-0 Usage
Uses
Used in Chemical Synthesis:
(2-CHLORO-ETHYL)-(2-CHLORO-2-PHENYL-ETHYL)-METHYL-AMINE is used as a reagent in chemical synthesis for its ability to participate in various organic reactions due to its amine functionality and the presence of chlorine atoms, which can be involved in substitution or addition reactions.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, (2-CHLORO-ETHYL)-(2-CHLORO-2-PHENYL-ETHYL)-METHYL-AMINE is used as an intermediate in the production of certain drugs. Its structural features allow it to be a key component in the synthesis of medicinal compounds, potentially contributing to the development of new therapeutic agents.
Used in Agrochemicals:
(2-CHLORO-ETHYL)-(2-CHLORO-2-PHENYL-ETHYL)-METHYL-AMINE is utilized as a precursor in the development of agrochemicals, such as pesticides and herbicides. Its chlorine-containing structure can be advantageous for enhancing the effectiveness of these products in controlling pests and weeds.
Used in Dye and Pigment Industry:
In the dye and pigment industry, (2-CHLORO-ETHYL)-(2-CHLORO-2-PHENYL-ETHYL)-METHYL-AMINE is used as a building block for the creation of novel dyes and pigments. The phenyl group in its structure can contribute to the color properties of these compounds, making it a valuable component in color chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 22270-22-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,2,7 and 0 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 22270-22:
(7*2)+(6*2)+(5*2)+(4*7)+(3*0)+(2*2)+(1*2)=70
70 % 10 = 0
So 22270-22-0 is a valid CAS Registry Number.
22270-22-0Relevant academic research and scientific papers
SUBSTITUTED PIPERAZINES AS CB1 ANTAGONISTS
-
Page/Page column 164; 165, (2009/03/07)
Compounds of Formula (I) or pharmaceutically acceptable salts, solvates, or esters thereof, are useful in treating diseases or conditions mediated by CB1 receptors, such as metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, addiction (e.g., smoking cessation), gastrointestinal disorders, and cardiovascular conditions.
Synthesis and pharmacological testing of 1,2,3,4,10,14b-hexahydro-6-methoxy-2-methyldibenzo[c,f]pyrazino[1,2-a]azepin and its enantiomers in comparison with the two antidepressants mianserin and mirtazapine
Wikstr?m, H?kan V.,Mensonides-Harsema, Marguérite M.,Cremers, Thomas I. F. H.,Moltzen, Ejner K.,Arnt, J?rn
, p. 3280 - 3285 (2007/10/03)
The synthesis and resolution of 1,2,3,4,10,14b-hexahydro-6-methoxy-2-methy[dibenzo[c,f]pyrazino [1,2-α]azepin (6-methoxymianserin, 6) are described. Furthermore, the in vitro and in vivo effects of 6 and its enantiomers are presented. 6 displayed high aff
